Adaptimmune Quarterly report pursuant to Section 13 or 15(d)

Accrued expenses and other current liabilities (Tables)

6 Months Ended

Jun. 30, 2020

Accrued expenses and other current liabilities consisted of the following (in thousands):


	June 30,		December 31,
	2020		2019
Accrued clinical and development expenditures	$	9,219	$	8,782
Accrued employee expenses		9,892		6,863
Other accrued expenditures		2,057		2,662
Accrued purchase commitments		2,500		5,000
Other		168		56
	$	23,836	$	23,363